Fimbristylis ovata extract and its ability to encounter AGEs-induced neurotoxicity in SH-SY5Y
Tóm tắt
Advanced glycation end products (AGEs) upon binding to its receptor (receptor for AGEs, RAGE) trigger several pathological processes involving oxidative stress and inflammatory pathway which play a pivotal role in various degenerative diseases including Alzheimer’s disease. Fimbristylis ovata (F. ovata) has long been reported to be used as a traditional herbal medicine; nonetheless, very few studies have been reported. In this study, the protective effects of F. ovata extract on neurotoxicity of hippocampal neuronal cells (SH-SY5Y) was investigated. When compared to normal control, AGEs treatment significantly induced oxidative stress level and enhanced NF-κB translocation to nucleus in the neuronal cells (p < 0.05). The increase in NF-κB translocation leads to increase in transcription level of the target genes including RAGE and pro-inflammatory cytokines which include interleukin 1 beta (IL1B), tumor necrosis factor-alpha (TNFA) and interleukin 6 (IL6). Pre-treatment of SH-SY5Y with the extracts of F. ovata shows favorable results by significantly suppressing oxidative stress level (p < 0.05) as well transcriptional level of RAGE (p < 0.05) and pro-inflammatory cytokines (p < 0.05). Chemical analysis of F. ovata extracts using High Resolution Liquid Chromatograph Mass Spectrometer (HR-LCMS) and Gas Chromatograph with high resolution Mass Spectrometer (GC-HRMS) suggested some potential active phytochemical compounds. The results from this study may provide possible alternative treatment for prevention and/or therapy of neurodegenerative disorders by targeting the above-mentioned pathways. The role of the phytochemical active ingredient (s) in inhibiting the AGEs-triggered signaling inflammatory pathway should be investigated in future study.
Tài liệu tham khảo
Sattler R, Tymianski M (2001) Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 24:107–129. https://doi.org/10.1385/MN:24:1-3:107
Hastings TG (2009) The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease. J Bioenerg Biomembr 41:469–472. https://doi.org/10.1007/s10863-009-9257-z
Yamagishi S (2011) Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Exp Gerontol 46:217–224. https://doi.org/10.1016/j.exger.2010.11.007
Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91:4766–4770. https://doi.org/10.1073/pnas.91.11.4766
Munch G, Mayer S, Michaelis J, Hipkiss AR, Riederer P, Muller R, Neumann A, Schinzel R, Cunningham AM (1997) Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. Biochem Biophys Acta 1360:17–29. https://doi.org/10.1016/S0925-4439(96)00062-2
Kamala A, Middha SK, Karigar CS (2018) Plants in traditional medicine with special reference to Cyperus rotundus L.: a review. 3 Biotech 8:309. https://doi.org/10.1007/s13205-018-1328-6
Arraki K, Totoson P, Decendit A, Badoc A, Zedet A, Jolibois J, Pudlo M, Demougeot C, Girard-Thernier C (2017) Cyperaceae species are potential sources of natural mammalian arginase inhibitors with positive effects on vascular function. J Nat Prod 80:2432–2438. https://doi.org/10.1021/acs.jnatprod.7b00197
Peerzada AM, Ali HH, Naeem M, Latif M, Bukhari AH, Tanveer A (2015) Cyperus rotundus L.: traditional uses, phytochemistry, and pharmacological activities. J Ethnopharmacol 174:540–560. https://doi.org/10.1016/j.jep.2015.08.012
Sunil AG, Kesavanarayanan KS, Kalaivani P, Sathiya S, Ranju V, Priya RJ, Pramila B, Paul FDS, Venkhatesh J, Babu CS (2011) Total oligomeric flavonoids of Cyperus rotundus ameliorates neurological deficits, excitotoxicity and behavioral alterations induced by cerebral ischemic–reperfusion injury in rats. Brain Res Bull 84:394–405. https://doi.org/10.1016/j.brainresbull.2011.01.008
Hemanth Kumar K, Tamatam A, Pal A, Khanum F (2013) Neuroprotective effects of Cyperus rotundus on SIN-1 induced nitric oxide generation and protein nitration: ameliorative effect against apoptosis mediated neuronal cell damage. NeuroToxicology 34:150–159. https://doi.org/10.1016/j.neuro.2012.11.002
Sukjamnong S, Santiyanont R (2012) Antioxidant activity of Fimbristylis ovata and its effect on RAGE gene expression in human lung adenocarcinoma epithelial cell line. J Chem Pharm Res 4:2483–2489. ISSN: 0975-7384
Sukjamnong S, Santiyanont R (2015) Effect of Fimbristylis ovata on receptor for advanced glycation end-products, proinflammatory cytokines, and cell adhesion molecule level and gene expression in U937 and bEnd.3 cell lines. Genet Mol Res 14:3984–3994. https://doi.org/10.4238/2015.April.27.13
Thomas S, Priya EJS (2015) Effect of Fimbristylis ovata (Burm. F) J. Kern on vero cell and MCF-7 cell morphology. J Chem Pharm Res 7:284–290. ISSN:0975-7384
Soman S, Raju R, Sandhya VK, Advani J, Khan AA, Harsha HC, Prasad TS, Sudhakaran PR, Pandey A, Adishesha PK (2013) A multicellular signal transduction network of AGE/RAGE signaling. J Cell Commun Signal 7:19–23. https://doi.org/10.1007/s12079-012-0181-3
Li J, Schmidt AM (1997) Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 272:16498–16506. https://doi.org/10.1074/jbc.272.26.16498
Mattson MP, Camandola S (2001) NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Investig 107:247–254. https://doi.org/10.1172/JCI11916
Lanzillotta A, Porrini V, Bellucci A, Benarese M, Branca C, Parrella E, Spano PF, Pizzi M (2015) NF-κB in innate neuroprotection and age-related neurodegenerative diseases. Front Neurol 6:98. https://doi.org/10.3389/fneur.2015.00098
Fogal B, Hewett SJ (2008) Interleukin-1beta: a bridge between inflammation and excitotoxicity? J Neurochem 106:1–23. https://doi.org/10.1111/j.1471-4159.2008.05315.x
Galic MA, Riazi K, Pittman QJ (2012) Cytokines and brain excitability. Front Neuroendocrinol 33:116–125. https://doi.org/10.1016/j.yfrne.2011.12.002
Abraham E (2000) NF-κB activation. Crit Care Med 28:N100–N104. https://doi.org/10.1097/00003246-200004001-00012
Tak PP, Firestein GS (2001) NF-κB: a key role in inflammatory diseases. J Clin Investig 107:7–11. https://doi.org/10.1172/JCI11830
Fuchs CS, Simon RC, Riethorst W, Zepeck F, Kroutil W (2014) Synthesis of (R)- or (S)-valinol using ω-transaminases in aqueous and organic media. Bioorg Med Chem 22:5558–5562. https://doi.org/10.1016/j.bmc.2014.05.055
Chen TT, Jiandong L, Wang G, Jiang SL, Li LB, Gao CQ (2013) Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery. Heart Surg Forum 16:E38–E47. https://doi.org/10.1532/HSF98.20121072
Teng Y, Feng C, Liu Y, Jin H, Gao Y, Li T (2018) Anti-inflammatory effect of tranexamic acid against trauma-hemorrhagic shock-induced acute lung injury in rats. Exp Anim 67:313–320. https://doi.org/10.1538/expanim.17-0143
Wang B (2009) Sialic acid is an essential nutrient for brain development and cognition. Annu Rev Nutr 29:177–222. https://doi.org/10.1146/annurev.nutr.28.061807.155515
Schnaar RL, Gerardy-Schahn R, Hildebrandt H (2014) Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol Rev 94:461–518. https://doi.org/10.1152/physrev.00033.2013
Dewanjee S, Maiti A, Das AK, Mandal SC, Dey SP (2009) Swietenine: a potential oral hypoglycemic from Swietenia macrophylla seed. Fitoterapia 80:249–251. https://doi.org/10.1016/j.fitote.2009.02.004
Sun YP, Jin WF, Wang YY, Wang G, Morris-Natschke SL, Liu JS, Wang GK, Lee KH (2018) Chemical structures and biological activities of limonoids from the genus Swietenia (Meliaceae). Molecules 23. https://doi.org/10.3390/molecules23071588
Oliveira LT, Leon GVO, Provance DW Jr, de Mello FG, Sorenson MM, Salerno VP (2015) Exogenous beta-amyloid peptide interferes with GLUT4 localization in neurons. Brain Res 1615:42–50. https://doi.org/10.1016/j.brainres.2015.04.026
de Nazareth AM (2017) Type 2 diabetes mellitus in the pathophysiology of Alzheimer’s disease. Dement Neuropsychol 11:105–113. https://doi.org/10.1590/1980-57642016dn11-020002
Li Y, Chi G, Shen B, Tian Y, Feng H (2016) Isorhamnetin ameliorates LPS-induced inflammatory response through downregulation of NF-κB signaling. Inflammation 39:1291–1301. https://doi.org/10.1007/s10753-016-0361-z
Choi YH (2016) The cytoprotective effect of isorhamnetin against oxidative stress is mediated by the upregulation of the Nrf2-dependent HO-1 expression in C2C12 myoblasts through scavenging reactive oxygen species and ERK inactivation. Gen Physiol Biophys 35:145–154. https://doi.org/10.4149/gpb_2015034
Ishola IO, Osele MO, Chijioke MC, Adeyemi OO (2019) Isorhamnetin enhanced cortico-hippocampal learning and memory capability in mice with scopolamine-induced amnesia: role of antioxidant defense, cholinergic and BDNF signaling. Brain Res 1712:188–196. https://doi.org/10.1016/j.brainres.2019.02.017
Wang X, Jiao X, Liu Z, Li Y (2017) Crocetin potentiates neurite growth in hippocampal neurons and facilitates functional recovery in rats with spinal cord injury. Neurosci Bull 33:695–702. https://doi.org/10.1007/s12264-017-0157-7
Zhang J, Wang Y, Dong X, Liu J (2018) Crocetin attenuates inflammation and amyloid-beta accumulation in APPsw transgenic mice. Immun Ageing 15:24. https://doi.org/10.1186/s12979-018-0132-9
Zhu A, Lao C, Wang Z, Chen Y, Bai C (2019) Characterization of crocetin-monoglucuronide as a neuron-protective metabolite of crocin-1. Mol Nutr Food Res e1900024. https://doi.org/10.1002/mnfr.201900024
Alison MD, Richard JP, Mark EH, Andrew DA (2003) The synthesis of naturally occurring vitamin K and vitamin K analogues. Curr Org Chem 7:1625–1634. https://doi.org/10.2174/1385272033486279
Netscher T (2007) Synthesis of vitamin E, vitamins & hormones. Academic Press, Cambridge, pp 155–202. https://doi.org/10.1016/S0083-6729(07)76007-739
Bourre JM (2004) Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging 8:163–174
Mahmoudi R, Ghareghani M, Zibara K, Tajali Ardakani M, Jand Y, Azari H, Nikbakht J, Ghanbari A (2019) Alyssum homolocarpum seed oil (AHSO), containing natural alpha linolenic acid, stearic acid, myristic acid and beta-sitosterol, increases proliferation and differentiation of neural stem cells in vitro. BMC Complement Altern Med 19:113. https://doi.org/10.1186/s12906-019-2518-4
Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205–214. https://doi.org/10.1038/nrd1330
Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20:148–160. https://doi.org/10.1038/s41583-019-0132-6
Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16:358. https://doi.org/10.1038/nrn3880